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During 2001, an outbreak of severe acute gastroen-
teritis swept through Central and northern Australia and
caused serious disruption to health services. We tracked
and characterized the rotavirus strain implicated in the out-
break. Comparison of the electropherotypes of outbreak
samples suggested that one G9P[8] strain was likely
responsible for the outbreak. Samples were obtained from
geographically distinct regions of Australia where the epi-
demic had occurred. The outbreak strains showed identical
nucleotide sequences in genes encoding three rotavirus
proteins, VP7, VP8, and NSP4, but they were distinct from
G9P[8] strains isolated in previous years. Several of the
amino acid substitutions on the VP7 and NSP4 proteins
were identified in regions known to influence function and
may have contributed to the emergence and increased
dominance of the outbreak strains. Rotavirus serotype sur-
veillance should continue with methods capable of identify-
ing new and emerging types.
R
otaviruses are the major cause of severe gastroenteri-
tis in young children worldwide. Surveillance studies
and serum antibody studies indicate that all young children
are likely to have had at least one rotavirus infection by the
time they are 3 years of age. Worldwide, approximately
400,000–600,000 children in developing countries die of
rotavirus-associated dehydration each year (1). Most
deaths occur in developing countries because of delays in
access to treatment. Despite low death rates in industrial-
ized countries, good hygiene and sanitation do not appear
to reduce the prevalence or prevent the spread of rotavirus. 
Since 1983, vaccines to protect against clinically severe
disease have been under development. The first vaccines
were aimed at providing specific protection against the
serotypes G1, G2, G3, and G4, which were predominant
since 1973 (2). Rotavirus surveillance programs in
Bangladesh (3), Brazil (4), India (5), the United States (6),
and Malawi (7) show that additional G types (G5, G6, G8,
G9, G10) can cause severe disease in children and are of
emerging importance in some communities. Serotype G9
is recognized as the most widespread of the emerging
serotypes and is now considered the fifth major G type.
The serotype has been identified since 1996 as a frequent
cause of severe disease in hospitalized children from many
countries, including the United States, Japan, India,
Bangladesh, France, Malawi, Nigeria, Australia, China,
Thailand, and the United Kingdom (3,6,8–12).
Characterizing rotaviruses into serotypes is based on
differences in genetic and antigenic structure of the two
outer coat proteins. The rotavirus genome is made up of 11
segments of double-stranded RNA located inside the core
of a triple-layered structure. The outer capsid proteins,
VP4 and VP7, elicit neutralizing antibody immune
responses that are both serotype-specific and cross-reac-
tive (13). Antigenic differences in VP4 and VP7 are the
basis of the classification into G (VP7 glycoprotein) and P
(protease-activated VP4 protein) serotypes. To date, 8 P
serotypes and 10 G serotypes have been identified in
humans by cross-neutralization tests (13,14). Epi-
demiologic studies have shown that serotypes G1, G2, G3,
and G4, associated with P1A[8] or P1B[4], have been the
most common serotypes to cause severe disease in children
worldwide in the 1980s and 1990s (2). Genetic and anti-
genic variation has been recorded within G1, G2, G3, and
G4 serotypes (15). G9 strains may be more susceptible to
genetic change than these other serotypes (3,16). 
The emergence of G9 strains in urban Australia in 1997,
together with the increasing prevalence and persistence of
this serotype, has had a major effect on healthcare services
in Australia (11). G9 strains were initially identified in
Central Australia in 1999 in 9% of children admitted to the
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strains were not detected in this area in 2000 (17). During
May 2001, one of the largest recorded outbreaks of severe
acute gastroenteritis in young aboriginal children from
remote and urban areas of Central Australia resulted in 246
emergency department visits and the hospitalization of 137
children at Alice Springs Hospital (18). All specimens from
hospitalized children were rotavirus positive. The epidemic
spread rapidly northward, causing outbreaks of rotavirus-
induced acute gastroenteritis in many communities spread
over 1 million km2 in the northern Territory and in outback
areas of southwestern Queensland and West Australia from
May through July 2001 (Figure 1). The National Rotavirus
Strain Surveillance Program received specimens from the
hospitalized patients. Serotype analysis indicated that G9
strains were responsible for the outbreak (11). 
This study describes the tracking and characterizing of
serotype G9P[8] strains implicated in the outbreaks in cen-
tral and northern Australia in 2001 and provides evidence
that the outbreaks were caused by a single strain. The
results highlight the importance of continued detailed epi-
demiologic and virologic studies of rotavirus serotypes
that cause severe gastroenteritis. 
Materials and Methods
Epidemiologic Features of Outbreaks
Alice Springs Hospital in Central Australia provides
tertiary medical care for approximately 43,000 people liv-
ing in a catchment area of >1 million km2. Approximately
28,000 people live in the city and 15,000 in small remote
communities that range from 12 to 800 persons (18).
Emergency transport to Alice Springs Hospital is provided
when necessary by the Royal Flying Doctor Service. Each
year epidemics of severe rotavirus diarrhea result in hospi-
talization of young children, usually during the cooler
months from May to August. In May 2001, “one of the
largest outbreaks of rotavirus in living memory swept
through Central Australia,” resulting in hospitalization of
137 children with confirmed rotavirus infection. Sixty-one
percent of these children were from remote regions. More
than 90% of the children were identified as aboriginal.
Fifty-nine percent were <12 months of age, and 96% were
<4 years of age (18). A much larger number of children
were less severely affected. At one stage, the Alice Springs
Hospital, the only hospital serving a scattered population
of 55,000 people, had 74 of its 164 beds occupied by chil-
dren with gastroenteritis. Extra nurses had to be flown
1,500 km from Darwin to assist (18). 
The epidemic moved northward during the next 2
months (June and July), causing an increase in the number
of children admitted to hospital with acute gastroenteritis
in centers such as Darwin and Gove. These towns are
>1,500 km from Alice Springs. In addition, cases of acute
gastroenteritis were identified in remote communities to
the northeast and northwest of Alice Springs, including
Mount Isa (Figure 1).
Stool Samples 
During 2001, a total of 348 specimens, examined by
enzyme immunosorbent assay (EIA) or heminested
reverse transcription–polymerase chain reaction (RT-PCR)
analysis, or both, were identified as serotype G9P[8].
Rotavirus G serotype was determined by using an in-house
EIA assay that incorporates neutralizing monoclonal anti-
bodies specific for G1, G2, G3, G4, and G9 antigens
(19,20). The EIA was supplemented by RT-PCR analysis
to determine G and P genotypes (21,22) The electro-
pherotypes of all 348 G9P[8] strains were determined by
polyacrylamide gel electrophoresis (PAGE) (20). 
Fifteen G9P[8] rotavirus–positive specimens were
selected for sequence analysis on the basis of electro-
pherotype, location, and timing of sample collection
(Table 1). Ten specimens were representative of strains
from the 2001 outbreak and included six specimens from
Alice Springs and the surrounding remote communities
(Docker River, Hermannsberg, and Maryvale); Gove,
Mount Isa, Darwin, and Perth were each represented by a
single specimen. Five G9P[8] strains collected from chil-
dren admitted to hospital in the cities of Alice Springs
(1999), Perth (1999), Sydney (1999), and Melbourne
(2000 and 2001) were used for comparison. 
RT-PCR Amplification
Rotavirus dsRNA was obtained from 10% fecal
extracts by using a standard phenol-chloroform extraction
and a hydroxyapatite purification method (23). The
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Figure 1. Map of Australia, indicating the locations where out-
breaks of acute rotavirus gastroenteritis were identified during
2001. The direction of spread is indicated. Darwin-Alice Springs
distance is 1,500 km.dsRNA gene segments, encoding proteins VP4, VP7,
NSP1, and NSP4, were reverse transcribed and amplified
by PCR.
Full-length gene 9 was amplified with primers Beg9
and End9 (21). For gene segment 4, primers con2 and con3
were used to amplify an 887-bp region encompassing the
VP8 subunit of the VP4 gene (22). Gene segment 10 was
amplified with primers complementary to the 3′ end of
each RNA segment (24). A 400-bp fragment of the gene
segment, encoding NSP1 protein, was amplified with
internal primers (25).
Sequence Analysis 
PCR products were purified with gel extraction and
spin column purification (Qiagen, Inc., Hilden, Germany).
The nucleotide sequence of each PCR product was deter-
mined in both directions with the dideoxynucleotide chain
terminator method with the BigDye sequencing kit (Perkin
Elmer-Applied Biosystems, Foster City, CA) and specific
oligonucleotide primers in an automated sequencer. 
Sequences of each gene segment were analyzed with
the Sequencher program (Gene Codes Corp., Inc., Ann
Arbor, MI) and subsequently compared with other
sequences by using E-CLUSTALW and analyzed by using
the DNAdist and Neighbor programs from PHYLIP soft-
ware accessed through BioManager, Australian Genomic
Information Service (ANGIS, University of Sydney). The
statistical significance of the constructed phylogenies was
analyzed with the Seqboot program to conduct bootstrap
analysis, with 100 replicates (26). Phylogenetic trees were
displayed with the Treeview program. The nucleotide
sequences for genes encoding the VP7, VP8, NSP4, and
NSP1 of the outbreak strains described in this study have
been deposited in GenBank sequence databank and
assigned the accession numbers AY629560–AY629562. 
Northern Hybridization Analysis
Northern hybridization analysis was carried out on four
Australian G9 strains isolated during 2001, two outbreak
strains from Alice Springs (Ob-AS -1 and Ob-AS-3) and
two nonoutbreak strains from Melbourne (MG9.06 and
Melb-G9.21). Northern hybridization was performed with
whole genome probes derived from virus strains F45
(G9,P1A[8], SGII, Wa genogroup) and RV-5 (G2,P1B[4],
SGI, DS1 genogroup). Probes were generated by labeling
cDNA, derived by reverse transcription of purified dsRNA
with random hexanucleotide primers and digoxigenin
(DIG)-11-dUTP. Northern hybridization was performed
with 10 ng/mL of probe and performed under stringent
conditions (24). 
Results
Epidemiologic Features of Rotavirus Outbreak
Serotype analysis of specimens obtained from children
hospitalized during the gastroenteritis epidemic showed
that rotavirus serotype G9 was the predominant type iden-
tified during the Central and northern Australian 2001 out-
break (Table 2) (17). Serotype G9 strains were the most
commonly identified 69% (111/161) in Alice Springs, 81%
(60/74) in Darwin, and 100% (31/31 and 25/25) in Gove
and Mount Isa. Serotype G9 represented 25.2% of speci-
mens from Western Australia. However, the results from
Western Australia include samples collected from two
regions, one urban (Perth) and the other remote communi-
ties in the northwestern Australian outback. G9 represent-
ed 18.6% in the urban collection and 45.1% in the remote
collection. All samples obtained during the epidemic out-
break (Alice Springs, Darwin, Gove, Mount Isa, and
Western Australia) had an identical long electropherotype
(Figure 2A), which was distinct from the patterns of
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Table 1. Characterization of rotavirus strains recovered from infants in outbreak and nonoutbreak settings 
Strains  Isolation location/date  Laboratory designation 
Outbreak (2001)     
Ob-Perth-1 Perth  3/26/2001  3084375 
Ob-AS-1  Alice Springs 5/12/2001  151572 
Ob-Her-1 Hermannsberg  5/12/2001  151496 
Ob-DR-1  Docker River 5/18/2001  152245 
Ob-MV-1 Maryvale  5/23/2001  152433 
Ob-AS-2  Alice Springs 5/25/2001  152704 
Ob-AS-3  Alice Springs 5/30/2001  153004 
Ob-Dar-1  Darwin 7/5/2001  6557 739 
Ob-MI-1  Mt Isa 7/12/2001  6504 7767 
Ob-Gv-1 Gove  8/7/2001  19522 
Nonoutbreak    
MG9.06 Melbourne  9/1/2000   
Melb- G.21  Melbourne 1/3/2001   
Syd-G9.1 Sydney  6/17/1999  991680093 
Perth G9.1  Perth 9/20/1999  326924 
AS-G9.1  Alice Springs 9/13/1999  8705 
 serotype G9 strains identified in other Australian locations
(Melbourne, Sydney, Perth, and Alice Springs) during pre-
vious rotavirus seasons (Figure 2B). 
Sequence Analysis
The gene encoding VP7 was sequenced for nine repre-
sentative strains isolated from several locations during the
outbreak (Ob-Perth-1, Ob-AS-1, Ob-Her-1, Ob-DR-1, Ob-
Mv-1, Ob-AS-3, Ob-Dar-1, Ob-MI-1, and Ob-Gv-1). The
VP7 genes were highly conserved, and all outbreak strains
were identical at both the nucleotide and amino acid level.
Comparison of the VP7 gene between the outbreak strains
and other serotype G9 strains isolated from 1999 to 2000
in Melbourne before the outbreak (MG9.06, Melb-G9.21,
and Syd-G9.1), Perth (Perth G9.1) and Alice Springs (AS-
G9.1), indicated a highly conserved gene. The VP7 genes
had nucleotide and amino acid homology of >99% identi-
ty. Alignment of the deduced amino acid sequences of the
VP7 gene showed three conserved amino acid substitu-
tions between the outbreak and nonoutbreak strains
(Figure 3). These were at position 242 (Asn–Ser) in the
antigenic F region, at position 68 (Ala–Val) in antigenic
region D and at amino acid position 40 (Leu–Phe), which
is outside of the major antigenic regions.
The nucleotide sequences of the VP8 subunit of the
VP4 gene were determined and compared for three out-
break strains (Ob-Perth-1, Ob-AS-1, and Ob-AS-2) and
two nonoutbreak strains (MG9.06, Melb-G9.21). Analysis
of the predicted amino acid sequence indicated that the
P[8] VP4 gene of all Australian serotype G9 strains (out-
break and nonoutbreak) had an F45-like P sublineage; 9 of
the 11 amino acid positions used to classify the P sublin-
eages were conserved with the F45-like residues (27). At
position 162, all of the Australian strains possessed the
Wa-lineage residue of arginine, and at position 195, a Gly
was observed rather than Asp or Asn. VP8 genes of the
outbreak and nonoutbreak strains differed. Comparison of
the amino acid sequences of the outbreak and nonoutbreak
strains showed three conserved differences at positions 21
(Glu–Lys), 91 (Ile–Val), and 249 (Val–Ile). 
The complete gene segment 10 sequence, encoding the
NSP4 protein, was determined for four outbreak strains
(Ob-Perth-1, Ob-AS-1, Ob-AS-3, and Ob-Dar-1) and two
nonoutbreak strains (MG9.06, Melb-G9.21). All of the
outbreak strains had identical nucleotide and deduced
amino acid sequences and at least 97% nucleotide identity
and amino acid homology with the nonoutbreak strains.
Alignment of the deduced amino acid sequences showed
five conserved differences, at aa53 (Thr–Ala), aa76
(Val–Ile), aa141 (Thr–Ile), aa142 (Ile–Val), and aa161
(Asn–Ser) between the outbreak and nonoutbreak strains.
Northern Hybridization Analysis
Northern hybridization analysis was conducted on the
Australian serotype G9 strains to investigate the genomic
relationship among the gene segments from the outbreak
and nonoutbreak strains (data not shown). Hybridization
results showed that 10 gene segments hybridized strongly
with the F45 whole genome probe, indicating that the
Australian G9 strains belong to the Wa genogroup. Gene
segment 5 of F45 failed to hybridize in all the outbreak and
nonoutbreak strains. Partial nucleotide sequence analysis
of the gene segment 5 (215-620 nt) NSP1 was conducted.
AGenBank search showed that this gene had greatest iden-
tity (95%) with gene 5 from the human neonatal strain
ST-3. Alignment of the deduced amino acid sequences
between the outbreak strains (Ob-AS-1 and Ob-AS-3) and
nonoutbreak strains (MG9.06 and Melb-G9.21) showed a
highly conserved region with no conserved amino acid
substitutions.
Tracking Rotavirus Outbreak G9P[8] Strain 
The temporal appearance of rotavirus G9 infections in
each of the geographic regions studied is illustrated in
Figure 4. On the basis of these results, the suggested direc-
tion of spread of this strain is indicated in Figure 1. The
rotavirus outbreak G9 strain was identified first in Perth,
Western Australia, in March/April, and then in Central
Australia, where the peak prevalence of rotavirus diarrhea
occurred in Alice Springs in May. The outbreak strain then
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Table 2. Serotyping results from Australian centers January–December, 2001 
% of rotavirus-positive samples by serotype 
Location n  G1 G2 G3 G4 G9 NT
a
Western  Australia         
Urban 306  67.5  0.3  0.3  –  18.6  15.1 
Remote 102  34.3  1  –  1  45.1  18.9 
Northern Australia (including Mt. Isa)               
Alice Springs    161  24.8  –  –  –  69  6.2 
Darwin 74  5.4  –  –  1  81  12.2 
Gove 31  –  –  –  –  100  – 
Mt. Isa   25  –  –  –  –  100  – 
Southern  Australia         
Melbourne  176  48.3 4.6  0  6.8 10.2  30.1 
aNontypeable results include samples with mixed serotype results and samples that do not react with any of the serotyping monoclonal antibodies.  spread rapidly northward to Darwin in June and July.
Outbreaks to the west (Docker River) and northeast
(Mount Isa, Gove) of Alice Springs were also identified
during June and July 2001. 
Discussion
We report the genetic characterization of rotavirus
G9P[8] strains isolated during the outbreak of severe
rotavirus diarrhea that occurred in Central Australia during
2001. Results described in this study comprising PAGE
analysis of all the outbreak strains and sequence analysis
of gene segments encoding VP7, VP8, and NSP4 from rep-
resentative strains illustrate that the Central Australian
rotavirus outbreak was the result of the spread of a single
strain of serotype G9. This strain was distinct from
serotype G9 strains present in Melbourne during the same
year (2001) and in previous rotavirus seasons in Alice
Springs and other Australian locations, including
Melbourne, Sydney, and Perth (28). 
Serotype G9 is the most widespread of the emerging
rotavirus serotypes. Recent epidemiologic studies suggest
that this type represents a common global serotype. In
Australia, serotype G9 has progressed from the initial
identification of three isolates in 1997 (10) to the second
most common serotype from 1999 through 2001, to
becoming the most common serotype in Australia during
2002 (40% of all isolates) and 2003 (74%) (11,17).
Similarly, serotype G9 was identified as the prevailing
serotype in several Japanese cities from 1998 through 2000
(29). 
This outbreak represented one of the largest outbreaks
of rotavirus disease in Central Australian history. The out-
break, strain while appearing to have its origins in urban
Perth, on the coast of Western Australia, had its major
effect on remote communities in Central Australia. During
May 2001, a total of 246 children with acute gastroenteri-
tis arrived at the emergency department of the Alice
Springs Hospital; 137 children were hospitalized. The out-
break stretched medical and staffing resources to capacity
(18). In Alice Springs, serotype G9 represented 69% of the
typeable strains. The predominance of serotype G9
increased with the northwards spread of the outbreak. The
tracking of this outbreak was possible because the timing
of the rotavirus activity varied by geographic location,
with each community being discrete and remote from the
others. This finding was highlighted in Darwin and Gove,
where 81% and 100% of the isolates were identified as
serotype G9, respectively. We have shown that the Central
Australian outbreak strain appeared to originate from
serotype G9 strains present in Perth, Western Australia,
during early 2001. The Perth G9P[8] strains possessed an
identical electropherotype and identical gene sequences
encoding for VP7, VP8, and NSP4 proteins to strains iso-
lated earlier during the Central Australian outbreak. 
The emergence and spread of the G9 “outbreak” strain
corresponded with several deduced amino acid changes in
viral proteins VP8, VP7, and NSP4 compared with nonout-
break strains from Melbourne, Sydney, Perth, and Alice
Springs. These proteins have previously been shown to
influence virulence of rotavirus strains (30,31). Conserved
changes in the gene coding for VP7 were identified in two
important antigenic regions (regions D and F). These
genetic changes likely affect the function of the VP7 pro-
tein virulence. One change is adjacent to the glycosylation
site Asn-X-Thr at residues 69–71, a site common to all
human rotavirus strains. The substitution at position 68
(Ala–Val) may influence glycosylation and hence alter the
antigenic reactivity of this virus. An effect of glycosylation
on virus antigenicity and virulence has been previously
postulated (30,32). Additional evidence that the removal or
addition of N-linked carbohydrates can influence viral
antigenicity comes from several studies using N-MAbs
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Figure 2. Electrophoretic patterns of the dsRNA of G9P[8] rotavirus
strains obtained from Australian children with acute gastroenteritis
during the rotavirus outbreak, 2001. Electropherotypes of four rep-
resentative G9P[8] strains isolated from children during the 2001
rotavirus outbreak are illustrated in part A. Lane 1, Alice Springs
(Ob-AS-1); lane 2, Darwin (Ob-Dar-1); lane 3, Gove (Ob-Gv-1); and
lane 4, Mount Isa (Ob-Gv-1). B) compares the electropherotypes of
G9P[8] strains isolated from children prior to the 2001 rotavirus out-
break with a strain isolated in Alice Springs during the 2001 out-
break. Lanes 1 and 8; Ob-AS-1, Lane 2; Alice Springs 1999, lane
3; Sydney 1999, lane 4; Perth 1999, lane 5; Melbourne 1999, lane
6; Melbourne 2000, lane 7; Melbourne 2001.
A B
1 2 3 4 5 6 7 8 1 2 3 4and polyclonal antiserum (32,33). The conserved substitu-
tion identified in the antigenic F region of the VP7 protein
may also be important in virulence. This antigenic region
has previously been shown to contain neutralization epi-
topes of serotype G9 viruses, and the region was only
accessible in viruses that lacked glycosylation site in this
region such as serotype G9 (33). This region may represent
an immunodominant region in G9 viruses. The alterations
in this region identified in this study may have altered the
antigenicity of the strains such that they were able to avoid
immune detection. This scenario has been used to explain
the reemergence of rotavirus serotypes, in particular
serotype G2, and the resultant intermittent epidemics.
Alterations in the antigenicity of rotavirus serotype G2
strains were conferred by amino acid substitutions in the
antigenic A region of the VP7 protein. A higher incidence
of infection with these strains occurred in older children in
the United Kingdom from 1995 through 1999, which sug-
gests that cross-protective antibody failed to afford protec-
tion against these serotype G2 strains (34). 
NSP4 has been shown to act as an enterotoxin in mice
and is involved in virus pathogenesis by acting as a recep-
tor for double-layered particles (35). Several studies have
found that NSP4 has been associated with altered viru-
lence, by sequence comparison of symptomatic and
asymptomatic strains isolated from serotypically identical
human strains (30,31) or symptomatic and asymptomatic
porcine strains tested in a mouse model (36), or by gene
reassortment studies in a piglet model (37). Our study has
identified changes in important regions of this protein of
the outbreak strain. Specifically, changes have been identi-
fied in a region of NSP4 critical for VP4 binding
(aa112–148) and in a region associated with membrane
destabilization (aa48–91) (38). These changes may affect
virus stability. NSP4 has been shown to elicit an immune
response in humans (39). However, the influence of these
changes identified on immune recognition is unknown,
since the antigenic regions are uncharacterized. 
The electropherotype of the G9P[8] outbreak strains
differed in the several respects from G9P[8] strains identi-
fied elsewhere in Australia from 1999 to 2001. Differences
were most apparent in the mobility of gene segments 2 and
3. As yet, no evidence shows that genes 2 and 3 (coding for
VP2 and VP3, respectively) are involved in virulence (37).
Northern hybridization analysis of both outbreak and
nonoutbreak serotype G9 strains had a similar hybridiza-
tion pattern. Ten of 11 segments hybridized to a Wa-like
probe, which indicated that these strains all belong to the
human Wa genogroup. Only gene segment 5, which
encodes the NSP1 protein, failed to hybridize. The gene 5
showed greatest identity to gene 5 of the P[6] strains ST3
and M37, rather than P[8] strains. Several studies have
shown that the G9 VP7 protein is capable of associating
with both VP4 proteins P[6] and P[8], in addition to VP6
proteins from subgroup I and II (3,16,40). Aprevious study
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Figure 3. Deduced amino acid
sequences of the VP7 antigenic
regions of rotavirus G9P[8] strains.
A) Outbreak strains. B) Nonoutbreak
strains. The VP7 sequences of the
standard G9 strain (US1206) and the
Australian nonoutbreak strains were
obtained from GenBank. Accession
numbers are as indicated: US1206:
AJ250271, Perth G9.1: AY307094,
Syd-G9.1: AY307093, MG9.06:
AY307085, Melb-G9.21: AY307090.
The sequence of rotavirus strains
F45 was obtained from Kirkwood et
al. (33). All other sequences were
determined in this study. A dash indi-
cates homology with the US1206
sequence at that position. 
Figure 4. Temporal appearance of rotavirus G9P[8] strains isolat-
ed from children admitted to hospital with acute gastroenteritis dur-
ing 2001. The monthly appearance of G9P[8] strains for each of
the collaborating laboratories is indicated. The Western Australia
results are divided in urban location (Perth) and remote outback
locations (remote-WA). has associated gene 5 with pathogenicity in the mouse
model (41). However, alterations in the gene 5 segment
cannot explain the emergence of this strain in Central
Australia since limited sequence analysis failed to identify
any genetic difference between the outbreak and nonout-
break G9 strains. The results from this study further high-
light the ability of serotype G9 strains to undergo
reassortment and extend this observation to include gene
segments that encode non-structural proteins. 
Rotavirus surveillance programs using molecular
assays have shown that most cases of acute gastroenteritis
are associated with the globally common serotypes,
G1–G4. However, the emergence of novel or rare
serotypes, including the identification of serotypes G5, G6,
G8, and G10, in children in many settings worldwide, has
highlighted a much greater strain diversity than previously
reported. The diversity of rotavirus strains has arisen
because of the strains ability to undergo genetic evolution.
A number of different mechanisms exist by which
rotavirus strains can evolve, ranging from reassortment of
single or multiple gene segments during mixed infections
by strains of human-human origin or human-animal origin
to generation of single point mutations in immunological-
ly important genes. In particular, serotype G9 strains
appear to have an enhanced capacity to reassort.
Epidemiologic studies have identified G9 strains in com-
bination with several different VP4 genogroups (P[4],
P[6], P[8], and P[11]) and with both VP6 subgroup anti-
gens (3,9,12,24,28,40). These mechanisms provide
rotavirus with a unique capacity to rapidly evolve, and pro-
duce strains that have the potential to be epidemiological-
ly important. Protection from rotavirus disease relies on
production of heterotypic immune responses after primary
infection. However, novel strains may avoid stimulating
preexisting immunity produced from previous rotavirus
infections because of the unique nature of the outer capsid
proteins. Outbreaks of acute gastroenteritis associated with
an unusual serotype G2 strain and serotype G9 are two
recent examples from Central Australia (42). Therefore,
the diversity of rotavirus serotypes has important implica-
tions for vaccine development, especially if strains that are
not targeted by current vaccine candidates continue to
emerge as common types either globally or regionally.
National surveillance data since 2001 highlights the
continued emergence of serotype G9 as the most prevalent
serotype nationally, which results in the replacement of
serotype G1 as the dominant strain for the first time since
Australian rotavirus surveillance began in 1993. This
study, which shows that a single rotavirus serotype G9
strain was responsible for a large epidemic of severe gas-
troenteritis in Central Australia, emphasizes that sequence
alterations on viral proteins may be implicated in virus vir-
ulence. Continued surveillance of rotavirus serotypes,
which includes the capacity to identify new and emerging
serotypes, is important for successfully developing and
implementing vaccines. 
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